Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and …
Press Release
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
In-person presentation on Wednesday, February 25th at 11:00 AM PTTAMPA, FL and LONDON – February 18, 2026 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology …
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategy Company also discusses its lead ADC …
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Live video webcast on Tuesday, February 10th at 1:00 PM EST TAMPA and LONDON – February 5, 2026 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology …
Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors
Company expands its ADC pipeline and patent estate for novel, differentiated ADCs New pipeline candidate AKTX-102 leverages Akari’s proprietary PH1 …
